In Hilarious Fashion, Trump Takes Questions From a New Spot at the White...
Democrats' Sudden Freakout Over Gerrymandering Is Starting to Make Sense...
This Officer Framed a 16-Year-Old in Sex Trafficking Hoax. The Courts Let Her...
The Ghoul Jim Acosta Performed a Ouija Board Interview
Georgia AG Moving Against Savannah's Gun Ordinance
Judge Rules State's Requirement for Open Carry Permits Constitutional
Illegal Chinese Immigrant, Accomplice Caught Smuggling U.S. Microchips to China
Defense Experts Break Down Trump’s Nuclear Sub Move
Elitist on the Taxpayer’s Dime: Democrat Feasts While His State Struggles
'Evil:' Schwarzenegger to Fight Newsom’s Plan to Redraw California Congressional Map
Paxton Cracks Down on Runaway Texas Democrats, Will Seek Judicial Orders
Trump Threatens to Impose Pharma Tariffs of Up to 250 Percent
Federal Judges Walk Back Rulings Seemingly Based on AI Testimonials
Trump Admin Moves to Ban Nearly All Abortions at Veterans Affairs Hospitals
Arkansas Judge Blocks 10 Commandments From School Buildings
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement